Global Bovine Respiratory Disease Treatment Market
According to the report " Bovine Respiratory Disease Treatment Market ", published by Market Data Forecast , the global market is projected to reach USD 67.31 Million by 2021 , at a CAGR of 22.4 % from 2016 to 2021 .
BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections , which can cause pneumonia . The disease is the most common and costliest problem encountered in stocker or feedlot calves .
The risk of bovine respiratory disease ( BRD ) has a significant effect on the value of cattle in the marketplace . Bovine respiratory disease can be a costly expense for cattle producers . It causes major economic losses to the producer by reducing average daily gain , feed efficiency , and overall performance of beef calves .
Global Bovine Respiratory Disease Treatment Market is segmented as follows .
1 . By Type of Treatment : �
� � � � �
Anti-Infectious Agents a ) Antibiotics b ) Sulfas Anti-Parasiticides Bronchodilators Oral Rehydration Fluids Non-Steroidal Anti-Inflammatories Mucolytics
2 . By Geography :
� � � � �
North America Europe Asia-Pacific Latin America Middle-East and Africa
The major companies dominating this market by their products and services are Zoetis Inc ., Merck & Co . Inc ., Bayer Corporation , Eli Lilly & Co ., Merial S . A . S , Boehringer Ingelheim Vetmedica , Novartis Animal Health , Vibrac S . A , Ceva Sante Animale and Vétoquinol S . A .
TABLE OF CONTENTS
1 . Introduction
1.1 Market Definition
1.2 Study Deliverables
+ 1 888-702-9626 | www . marketdataforecast . com | contact @ marketdataforecast . com